Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38ec8c49ce1122e1361ab404050fe915 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5012d58bb33dc9709ccad873df226cd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97405158b2766db5472bd7755dc4f90f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 |
filingDate |
1995-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24310eda345ea37881734b7d421fbaa5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97dfd15a46b25769aa5064599a50020b |
publicationDate |
1996-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9602269-A1 |
titleOfInvention |
Therapeutic method and compounds of use therein |
abstract |
The use of amylin as an agent for stimulation of bone growth is provided together with methods of stimulating bone growth comprising subjecting bone to an effective amount of amylin or amylin agonists. Medicaments containing amylin or an amylin agonist are provided. The amylin or amylin agonist is preferably in the form in which the presence of TFA is minimised or totally removed. Preferably a salt with an inert anion is used. The method will be particularly useful in treating bone disorders where stimulation of bone growth is required. The treatment of osteoporosis, bone loss of malignancy, or endocrine disorders or arthritides or immobility and disuse and in fractures are examples of the many disorders which may be treated. Previous bone loss can be reversed, and bone density can be increased or maintained. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208469-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9916406-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0904094-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9916406-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6821954-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0904094-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208468-B2 |
priorityDate |
1994-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |